February 26, 2019
Strongbridge Biopharma plc Reports Fourth Quarter and Full-Year 2018 Financial Results
Media
February 25, 2019
GenSight Biologics completes a capital increase of €8 million without discount subscribed entirely by Sofinnova
February 22, 2019
Modus announces First Cohort Dosed in U.S. Phase 1 Study of Subcutaneously Administered Sevuparin
February 22, 2019
BONESUPPORT – Publication of a clinical study highlighting Vancomycin release from CERAMENT® V in major hip surgery
February 22, 2019
Oncopeptides Year-end Report 2018
February 21, 2019
Rainier Therapeutics to Participate in the SVB Leerink Global Healthcare Conference
February 20, 2019
BONESUPPORT HOLDING AB (publ) – Invitation to conference call in connection of the Full Year Report 2018
February 19, 2019
Strongbridge Biopharma plc to Host Fourth Quarter and Year-End 2018 Financial Results Conference Call on February 26, 2019
February 19, 2019
Q4 2018 General Market Overview
February 18, 2019
Q4 2018 General Market Overview
